NCT05041647View on ClinicalTrials.gov

Cannabinoids As a Treatment for Insomnia in Major Depression

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 28, 2023

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
InsomniaDepressive Disorder, MajorSleep DisorderDepressionInsomnia Chronic
Interventions
DRUG

25:1 CBD/THC

"* 1 dose (1 mL) of HIGH CBD~* 50 mg/ml CBD and 2 mg/ ml THC"

DRUG

5:1 CBD/THC

"* 1 dose (1 mL) of LOW CBD~* 10 mg/ml CBD and 2 mg/ ml THC"

OTHER

Placebo

"* 1 dose (1 mL) of PLACEBO~* No active ingredients"

Trial Locations (1)

L9C 0E3

St. Joseph's Healthcare Hamilton, Hamilton

All Listed Sponsors
collaborator

McMaster University

OTHER

lead

St. Joseph's Healthcare Hamilton

OTHER

NCT05041647 - Cannabinoids As a Treatment for Insomnia in Major Depression | Biotech Hunter | Biotech Hunter